KERALA AYURVEDA
Back to Balance Sheet
|
KERALA AYURVEDA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹23 Cr | ₹65 Cr | ₹55 Cr | ₹42 Cr | ₹67 Cr |
What is the latest Total Non-Current Liabilities ratio of KERALA AYURVEDA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹65 Cr |
| Mar2023 | ₹55 Cr |
| Mar2022 | ₹42 Cr |
| Mar2021 | ₹67 Cr |
How is Total Non-Current Liabilities of KERALA AYURVEDA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹23 Cr | -64.52 | |
| Mar2024 | ₹65 Cr | 19.29 | |
| Mar2023 | ₹55 Cr | 30.65 | |
| Mar2022 | ₹42 Cr | -37.36 | |
| Mar2021 | ₹67 Cr | - | |
Compare Total Non-Current Liabilities of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹237.7 Cr | -10% | -20.7% | -40.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,999.0 Cr | 3.6% | 7% | 15.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,139.0 Cr | 1.1% | 5.8% | 14.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,791.0 Cr | 1.9% | 12.3% | 49.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,664.0 Cr | 1.8% | 5.9% | 14.8% | Stock Analytics | |
| CIPLA | ₹107,685.0 Cr | 1.6% | 0.2% | -5.4% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | -10% |
-20.7% |
-40.7% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses